Sheng Yao
yaosheng@simm.ac.cn
Chinese, English, German
Shanghai
University of Chinese Academy of Sciences
Medical School
  • 2005-09--2008-07 PhD in Science: Shanghai Institute of Materia Medica, Chinese Academy of Sciences
  • 2002-09--2005-07 MSc in Science: China Pharmaceutical University, School of Traditional Chinese Medicine
  • 1998-09--2002-07 MSc in Medicine: Wuhan University, School of Pharmacy
  • 2022-07~Present - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher, Group Leader, Doctoral Supervisor
  • 2017-10~2022-07 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Researcher
  • 2012-10~2017-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Associate Researcher
  • 2008-11~2011-01 - Wuppertal University, Germany - Postdoctoral Researcher
  • 2008-08~2012-09 - Shanghai Institute of Materia Medica, Chinese Academy of Sciences - Assistant Researcher
Discovery of novel active natural products with unique structures
Research on the pharmacological basis of traditional Chinese medicine
Discovery, structural modification, and optimization of natural lead compounds
  • Naringenin improves muscle endurance via activation of the Sp1-ERRg transcriptional axis, zhenyu lv, Jiao Meng, Sheng Yao, Fu Xiao, Shilong Li, Haoyang Shi, Chen Cui, Kaixian Chen, Xiaoming Luo, Yang Ye, Chang Chen, 2023
  • Pharmacological characterization of the small molecule 03A10 as an inhibitor of α-synuclein aggregation for Parkinson's disease treatment, Qing Wang, Sheng Yao, Ze-xian Yang, Chen Zhou, Yu Zhang, Ye Zhang, Lei Zhang, Jin-Tian Li, Zhi-Jian Xu, Wei-Liang Zhu, Nai-Xia Zhang, Yang Ye, Lin-Yin Feng, 2023
  • Flavonoids from the roots and rhizomes of Sophoratonkinensis and their in vitro anti-SARS-CoV-2 activity, Zhuo LI, Hang XIE, Chunping TANG, Lu FENG, Changqiang KE, Yechun XU, Haixia SU, Sheng YAO, Yang YE, 2023
  • Naphthylisoquinoline alkaloids, a new structural template inhibitor of Nav1.7 sodium channel, Wang, Qiaoqiao, Wang, Long, Zhang, Wenbo, Tang, Chunping, Chen, Xueqin, Zheng, Yueming, Yao, Sheng, Gao, Zhaobing, Ye, Yang, 2023
  • Withaphysalins from Medicinal and Edible Physalis minima and Their Anti-inflammatory Activities, Hu, Bintao, Li, Han, Tang, Chunping, Ke, ChangQiang, Geng, Meiyu, Yao, Sheng, Xie, Zuoquan, Ye, Yang, 2022
  • Fused-ring α-pyrones from intramolecular C–H activation and their lipids-lowering activity associated with LXR-IDOL-LDLR axis regulation, Yingle Mao, Jiaomeng Li, Chunping Tang, Biao Ma, Zhijian Xu, Changqiang Ke, Lu Feng, Haiyan Zhang, Sheng Yao, HuiXiong Dai, Yang Ye, 2022
  • Discovery of potential small molecular SARS-CoV-2 entry blockers targeting the spike protein, Wang, Lin, Wu, Yan, Yao, Sheng, Ge, Huan, Zhu, Ya, Chen, Kun, Chen, Wenzhang, Zhang, Yi, Zhu, Wei, Wang, Hongyang, Guo, Yu, Ma, Peixiang, Ren, Pengxuan, Zhang, Xianglei, Li, Huiqiong, Ali, Mohammad A, Xu, Wenqing, Jiang, Hualiang, Zhang, Leike, Zhu, Lili, Ye, Yang, Shang, Weijuan, Bai, Fang, 2022
  • Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease, Su, Haixia, Yao, Sheng, Zhao, Wenfeng, Zhang, Yumin, Liu, Jia, Shao, Qiang, Wang, Qingxing, Li, Minjun, Xie, Hang, Shang, Weijuan, Ke, Changqiang, Feng, Lu, Jiang, Xiangrui, Shen, Jingshan, Xiao, Gengfu, Jiang, Hualiang, Zhang, Leike, Ye, Yang, Xu, Yechun, 2021
  • Anti-inflammatory Eudesmane Sesquiterpenoids from Artemisia hedinii, Wang, Xing, Peng, Xia, Tang, Chunping, Zhou, Shuaizhen, Ke, ChangQiang, Liu, Yueling, Yao, Sheng, Ai, Jing, Ye, Yang, 2021
  • Sesquiterpene lactone dimers from Artemisia lavandulifolia inhibit interleukin-1 beta production in macrophages through activating autophagy, Wang, Qiaoqiao, Zhang, Tian, Ke, ChangQiang, Tang, Chunping, Yao, Sheng, Lin, Ligen, Ye, Yang, 2020
  • Gigantol ameliorates CCl4-induced liver injury via preventing activation of JNK/cPLA2/12-LOX inflammatory pathway, Yaru Xue, Qiangqiang Deng, Qingli Zhang, Zhenghua Ma, Binfan Chen, Xiaolu Yu, Huige Peng, Sheng Yao, Jia Liu, Yang Ye, Guoyu Pan, 2020
  • Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients, Su, Haixia, Yao, Sheng, Zhao, Wenfeng, Li, Minjun, Liu, Jia, Shang, Weijuan, Xie, Hang, Ke, Changqiang, Hu, Hangchen, Gao, Meina, Yu, Kunqian, Liu, Hong, Shen, Jingshan, Tang, Wei, Zhang, Leike, Xiao, Gengfu, Ni, Li, Wang, Daowen, Zuo, Jianping, Jiang, Hualiang, Bai, Fang, Wu, Yan, Ye, Yang, Xu, Yechun, 2020
  • Neuroprotective and Anti-inflammatory Ditetrahydrofuran-Containing Diarylheptanoids from Tacca chantrieri, Yang, Yue, Gong, Qi, Wang, Wei, Mao, YingLe, Wang, XiaoRong, Yao, Sheng, Zhang, HaiYan, Tang, Chunping, Ye, Yang, 2020
  • Targeted isolation of two disesquiterpenoid macrocephadiolides A and B fromAinsliaea macrocephalausing a molecular networking-based dereplication strategy, Ren, YongMei, Zhou, ShuaiZhen, Zhang, Tian, Qian, Meijia, Zhang, Rui, Yao, Sheng, Zhu, Hong, Tang, Chunping, Lin, Ligen, Ye, Yang, 2020
  • Tricarabrols A-C, three anti-inflammatory sesquiterpene lactone trimers featuring a methylene-tethered linkage from Carpesium faberi, Yuan, Jie, Wen, Xuelan, Ke, ChangQiang, Zhang, Tian, Lin, Ligen, Yao, Sheng, Goodpaster, Jason D, Tang, Chunping, Ye, Yang, 2020
  • Bufalin exerts antitumor effects in neuroblastoma via the induction of reactive oxygen species-mediated apoptosis by targeting the electron transport chain, Pan, Lijia, Nie, Litong, Yao, Sheng, Bi, Aiwei, Ye, Yang, Wu, Yeming, Tan, Zhen, Wu, Zhixiang, 2020
  • Discovery and characterization of natural products as novel indoleamine 2,3-dioxygenase 1 inhibitors through high-throughput screening, Guo Wei, Yao Sheng, Sun Pu, Yang Tianbiao, Tang Chunping, Zheng Mingyue, Ye Yang, Meng Linghua, 2020
  • 3-Deoxy-2β,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/ STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells, Hui Shan, Sheng Yao, Yang Ye, Qiang Yu, 2019
  • Pretreatment with broad-spectrum antibiotics alters the pharmacokinetics of major constituents of Shaoyao-Gancao decoction in rats after oral administration, Liu Meng, Yuan Jie, Hu Wenjuan, Ke Changqiang, Zhang Yifan, Ye Yang, Zhong Dafang, Zhao Guangrong, Yao Sheng, Liu Jia, 2019
  • A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation, Wang, Yumeng, Huang, Haixia, Yao, Sheng, Li, Guiling, Xu, Congjian, Ye, Yang, Gui, Suiqi, 2019
  • Pyrrole-Hemoglobin Adducts, a More Feasible Potential Biomarker of Pyrrolizidine Alkaloid Exposure, Ma, Jiang, Ruan, Jianqing, Chen, Xinmeng, Li, Dongping, Yao, Sheng, Fu, Peter P, Ye, Yang, Gao, Hong, Wang, Jiyao, Lin, Ge, 2019
  • 3-Deoxy-2 beta,16-dihydroxynagilactone E, a natural compound from Podocarpus nagi, preferentially inhibits JAK2/STAT3 signaling by allosterically interacting with the regulatory domain of JAK2 and induces apoptosis of cancer cells, Shan, Hui, Yao, Sheng, Ye, Yang, Yu, Qiang, 2019
  • Cytotoxic Germacrane-Type Sesquiterpene Lactones from the Whole Plant of Carpesium lipskyi, Zhu, NanLin, Tang, Chunping, Xu, Chenghui, Ke, ChangQiang, Lin, Ge, Jenis, Janar, Yao, Sheng, Liu, Hongchun, Ye, Yang, 2019
  • Lycodine-type alkaloids from Lycopodiastrum casuarinoides and their acetylcholinesterase inhibitory activity, Feng, Zheling, Chen, Shixin, Wang, Wei, Feng, Lu, Dong, Yanyan, Zou, Yiping, Ke, Changqiang, Tang, Chunping, Yao, Sheng, Zhang, Haiyan, Gan, Lishe, Ye, Yang, Lin, Ligen, 2019
  • Discovery of a novel protein kinase C activator from Croton tiglium for inhibition of non-small cell lung cancer, Wang Yuwei, Tang Chunping, Yao Sheng, Lai Huanling, Li Runze, Xu Jiahui, Wang Qianqian, Fan Xing Xing, Wu Qi Biao, LaiHan, Leung Elaine, Ye Yang, Yao Xiaojun, 2019
  • Tetramerized Sesquiterpen
Natural Products Active Compounds Unique Structures Pharmacological Basis Traditional Chinese Medicine Lead Compounds Structural Modification Optimization Discovery Research

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.